ClinicalTrials.gov
public full text
Public Domain
A Study of JNJ-30979754 (Decitabine) in Patients With Myelodysplastic Syndrome
The purpose of this study is to to determine the recommended dose level of JNJ-30979754 (decitabine) as well as to assess the safety and effectiveness in patients with Myelodysplastic Syndrome (MDS).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study of Three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS)#1088817
- A Study of Decitabine Given to Adults With Advanced-Stage Myelodysplastic Syndromes#918932
- Lenalidomide and Decitabine in High Grade Myelodysplastic Syndromes#1010622
- A Phase Ⅳ Study of Decitabine in Myelodysplastic Syndrome#1173355
- An Effectiveness and Safety Study of Decitabine in Patients With Myelodysplastic Syndrome#914388
Record · ID 1115164
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive